Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Surrozen, Inc./DE (SRZN) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Surrozen, Inc./DE (SRZN), most recent 12 months reported: revenue $11.51M, net loss $332.13M, free cash flow -$34.98M. Latest balance sheet on file: liquid cash $102.04M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): Alector, Inc. · CRISPR THERAPEUTICS AG · Lineage Cell Therapeutics, Inc. · ELUTIA INC. · Relay Therapeutics, Inc. · Caribou Biosciences, Inc. · TSCAN THERAPEUTICS, INC. · ZEO SCIENTIFIX, INC

Stock screener

Watchlist